As such, many elderly cognitively unimpaired (CU) individuals exhibit considerable Aβ proteinopathy without manifest cognitive deficits (that is, at age 70 years, PET-assessed Aβ positivity is ~23%, which increases to ~48% when carrying at least one APOE ε4 allele)5,6. This evidence concerns the gene APOE and Cognitive impairment.